Ekso Bionics Holdings Inc
NASDAQ:EKSO
Ekso Bionics Holdings Inc
NASDAQ:EKSO
Price:
1.25 USD
-2.34%
Market Closed
Updated:
Apr 29, 2024
Ekso Bionics Holdings Inc
Cash from Operating Activities
|
Ekso Bionics Holdings Inc
Cash from Operating Activities Peer Comparison
Comparables:
BDX
BSX
SYK
ABT
ISRG
Competitive Cash from Operating Activities Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Cash from Operating Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Ekso Bionics Holdings Inc
NASDAQ:EKSO
|
Cash from Operating Activities
-$12.1m
|
CAGR 3-Years
-11%
|
CAGR 5-Years
11%
|
CAGR 10-Years
-82%
|
|
|
Becton Dickinson and Co
NYSE:BDX
|
Cash from Operating Activities
$3.4B
|
CAGR 3-Years
-8%
|
CAGR 5-Years
4%
|
CAGR 10-Years
8%
|
|
|
Boston Scientific Corp
NYSE:BSX
|
Cash from Operating Activities
$2.5B
|
CAGR 3-Years
18%
|
CAGR 5-Years
52%
|
CAGR 10-Years
8%
|
|
|
Stryker Corp
NYSE:SYK
|
Cash from Operating Activities
$3.7B
|
CAGR 3-Years
4%
|
CAGR 5-Years
7%
|
CAGR 10-Years
7%
|
|
|
Abbott Laboratories
NYSE:ABT
|
Cash from Operating Activities
$7.3B
|
CAGR 3-Years
-10%
|
CAGR 5-Years
4%
|
CAGR 10-Years
9%
|
|
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
Cash from Operating Activities
$1.7B
|
CAGR 3-Years
2%
|
CAGR 5-Years
7%
|
CAGR 10-Years
8%
|
See Also
What is Ekso Bionics Holdings Inc's Cash from Operating Activities?
Cash from Operating Activities
-12.1m
USD
-12.1m
USD
Based on the financial report for Dec 31, 2023, Ekso Bionics Holdings Inc's Cash from Operating Activities amounts to -12.1m USD.
What is Ekso Bionics Holdings Inc's Cash from Operating Activities growth rate?
Cash from Operating Activities CAGR 10Y
-82%
-82%
Over the last year, the Cash from Operating Activities growth was 18%. The average annual Cash from Operating Activities growth rates for Ekso Bionics Holdings Inc have been -11% over the past three years , 11% over the past five years , and -82% over the past ten years .
You don't have any saved screeners yet
